title: Hybrid lentiviral vectors.
abstract: Lentiviral vectors have remarkable cell entry and gene delivery properties that make them highly attractive for gene therapy. However, all integration-competent gene delivery systems have come under scrutiny for possible adverse insertional events. Circumventing the risk of insertional mutagenesis, integration-deficient human immunodeficiency virus (HIV)-1-derived vectors have been shown to support durable transcription of transgenes in certain nonmitotic cell lineages. In mitotic cell populations, such nonintegrated viral forms are lost during cell division and so have time-limited effects. Hybrid lentiviral vectors that harness the cell entry properties of HIV to facilitate carriage of alternative DNA modification systems into cells may allow durable genetic modification with more favorable integration profiles. Thus, systems, which have previously been plasmid-based such as those based on nuclease-enhanced homologous recombination (HR) and artificial transposons, have been incorporated into the viral genome to allow them to "hitch-hike" into cells that are difficult to transfect. Here, we review recent progress in the development of such hybrid lentiviral systems and consider potential applications of such vectors.
authors.affiliation: Molecular Immunology Unit, Institute of Child Health, University College London, London, UK. w.qasim@ich.ucl.ac.uk
authors.forename: Waseem
authors.initials: W
authors.lastname: Qasim
authors.forename: Conrad A
authors.initials: CA
authors.lastname: Vink
authors.forename: Adrian J
authors.initials: AJ
authors.lastname: Thrasher
mesh_terms: D005822:Genetic Vectors / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics; D016086:Lentivirus / Q000235:genetics*; D008957:Models, Genetic
references.citation: J Clin Invest. 2008 Sep;118(9):3132-42
references.pmid: 18688285
references.citation: Mol Ther. 2009 Jul;17(7):1205-14
references.pmid: 19240688
references.citation: Mol Cell Biol. 2003 Dec;23(23):8505-18
references.pmid: 14612396
references.citation: PLoS One. 2007 Dec 19;2(12):e1340
references.pmid: 18092005
references.citation: Nat Biotechnol. 2007 Nov;25(11):1298-306
references.pmid: 17965707
references.citation: Science. 2009 Nov 6;326(5954):818-23
references.pmid: 19892975
references.citation: Cell. 2005 Aug 12;122(3):473-83
references.pmid: 16096065
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17372-7
references.pmid: 17090675
references.citation: Nat Med. 2006 Mar;12(3):348-53
references.pmid: 16491086
references.citation: Mol Cell. 2004 Jan 30;13(2):279-90
references.pmid: 14759372
references.citation: Mol Ther. 2008 Feb;16(2):352-358
references.pmid: 28178540
references.citation: J Biol Chem. 2002 Sep 13;277(37):34581-8
references.pmid: 12082109
references.citation: Nature. 2005 Jun 2;435(7042):646-51
references.pmid: 15806097
references.citation: Mol Ther. 2009 Nov;17(11):1919-28
references.pmid: 19672245
references.citation: J Biol Chem. 2003 Aug 29;278(35):33528-39
references.pmid: 12796494
references.citation: Mol Ther. 2009 Jul;17(7):1197-204
references.pmid: 19417741
references.citation: Mol Cell Biol. 2007 Dec;27(24):8824-33
references.pmid: 17938204
references.citation: Nat Med. 2006 Apr;12(4):401-9
references.pmid: 16582916
references.citation: Genesis. 2009 Jun;47(6):404-8
references.pmid: 19391106
references.citation: Cell. 2002 Aug 23;110(4):521-9
references.pmid: 12202041
references.citation: J Virol. 2001 Sep;75(17):7944-55
references.pmid: 11483739
references.citation: Nat Biotechnol. 2007 Jul;25(7):778-85
references.pmid: 17603475
references.citation: Mol Ther. 2007 Jun;15(6):1137-44
references.pmid: 17426709
references.citation: Mol Ther. 2009 Aug;17(8):1305-6
references.pmid: 19644491
references.citation: Nat Biotechnol. 2008 Jul;26(7):808-16
references.pmid: 18587387
references.citation: PLoS Pathog. 2006 Jun;2(6):e60
references.pmid: 16789841
references.citation: Gene Ther. 2010 Feb;17(2):150-7
references.pmid: 19847206
references.citation: Cell. 1997 Nov 14;91(4):501-10
references.pmid: 9390559
references.citation: J Virol. 1987 Feb;61(2):336-43
references.pmid: 3027365
references.citation: J Clin Invest. 2008 Sep;118(9):3143-50
references.pmid: 18688286
references.citation: Science. 2006 Oct 20;314(5798):461-4
references.pmid: 16959972
references.citation: BMC Biotechnol. 2008 Aug 09;8:60
references.pmid: 18691430
references.citation: Mol Ther. 2007 Dec;15(12):2107-13
references.pmid: 17998901
references.citation: Nat Biotechnol. 2007 Jul;25(7):786-93
references.pmid: 17603476
references.citation: Mol Cell Biol. 2005 Mar;25(6):2085-94
references.pmid: 15743807
references.citation: PLoS Comput Biol. 2006 Nov 24;2(11):e157
references.pmid: 17166054
references.citation: Nature. 2008 Nov 6;456(7218):107-11
references.pmid: 18987743
references.citation: J Virol. 1986 Nov;60(2):683-92
references.pmid: 3490582
references.citation: Nat Biotechnol. 2006 Jun;24(6):687-96
references.pmid: 16732270
references.citation: Mol Ther. 2008 Dec;16(12):1968-76
references.pmid: 18797449
references.citation: Mol Ther. 2002 Nov;6(5):570-1
references.pmid: 12409254
references.citation: Mol Ther. 2007 Nov;15(11):1947-54
references.pmid: 17700544
references.citation: Mol Ther. 2009 May;17(5):844-50
references.pmid: 19259065
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18786-91
references.pmid: 19843699
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17684-9
references.pmid: 17095605
references.citation: Mol Ther. 2009 Aug;17(8):1316-32
references.pmid: 19491821
references.citation: Mol Ther. 2006 Jun;13(6):1121-32
references.pmid: 16556511
references.citation: Mol Ther. 2009 Jan;17(1):121-30
references.pmid: 18985029
references.citation: Science. 2003 Oct 17;302(5644):415-9
references.pmid: 14564000